- Reduced price

Order to parcel locker
easy pay
Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details
Pay with a quick bank transfer, payment card or cash on delivery. Click for more details
If you are a consumer, you can return the goods within 14 days. Click for more details
Written by one of the foremost authorities on clinical trials, drug development, and regulatory affairs, Guide to Drug Development is a comprehensive review of the principles and activities involved in developing new drugs, devices, and other medical products. The book covers many topics not discussed in any other textbook and includes timely discussions on electronic clinical trials, registries of clinical trials, data mining, computer simulations and modeling, and changing regulatory standards.
Each chapter includes practical tips, lessons, guides, firsthand stories, quotes from experts, and three to six questions for group discussion. The last three chapters present twelve case studies each on clinical trials, regulatory affairs, and management of drug development.
Spilkers Guide to Drug Development will be the standard reference text for everyone working on or studying drug discovery or development, in industry, academia, hospitals, government, and independent laboratories.
Data sheet
SECTION 1
Introduction and Overview of a Company and the IndustryIntroduction to Drug Development
Pharmaceutical Industry:: Definitions
The Big Picture
Standards:: Types, Uses, and Issues
Pharma-think, Academic-think, and Government-think
Pharma Sense versus Common Sense
Section 2
Basic Principles, Strategies, and Approaches
Overview of Factors Affecting Drug Discovery
The Drug Discovery Process
Golden Rules of Drug Discovery
The Drug Development Process
Golden Rules of Drug Development
Biotechnology
Extrapolating Animal Safety and Efficacy Data to Humans
Evaluating and Interpreting Data
Stimulating Innovation and Increasing Efficiency with the Right Questions, People, Milieu, and Approaches
A New Paradigm of Drug Development
Future Environments for Drug Discovery and Development
Section 3
Corporate Organization and Management Issues
Models of International Operations
Organization at the Corporate Level
Corporate Management
Reducing Pharmaceutical Risk
Enhancing Communication
Personnel and Staffing Issues
Competitive Intelligence
Conflicts of Interest and Bias
Crisis Management
Mergers, Joint Ventures, and Alliances
Pharmacopolitics
Institutional Memory
Differences among Pharmaceutical Companies
Section 4
External Corporate Relationships and Interactions
Interactions and Relationships between Academicians and Industry
Investigator-sponsored Research Proposals Submitted to Industry
Technology Transfer from Academia to Industry
Interactions between Pharmaceutical Companies
Interactions with Trade Associations
Interactions with Legislators and Government Agencies
Interactions and Relationships with Healthcare Professionals
Interactions with Patients and the Public
Patient Package Inserts
Interactions and Relationships with the Media
Section 5
Research and Development Organization, Management, and Assessments
Organizing Research and Development
Managing Research and Development and Avoiding Tangents
Personnel Issues in Drug Discovery and Development
Myths about the Pharmaceutical Industry and Drug Development
Fads and Fashions in Drug Development
The Many Facets of Reality:: Approaches to Issues and Problems
International Organization and Management
Project Management:: Balancing Line Function and Matrix Approaches
Choosing the Number and Types of Drugs to Develop
Choosing Standards for Developing Drugs
Creating and Using Benchmarks
Evaluating a Portfolio of Investigational Drug Projects
Compassionate Use Programs
Virtual Drug Development
Developing and Marketing Orphan Drugs for Rare Diseases
Productivity and Project Success
Overview of Safety and Risk Management
Developing Standard Operating Procedures
Section 6
Clinical Activities and Issues
Introduction to Clinical Trials
Creating a Clinical Strategy and Development Plan for a New Drug or Indication
Designing and Implementing a Clinical Trial
Questions to Ask about a Clinical Trial Protocol
Dose-esponse Relationships in Clinical Trials
Collecting and Interpreting Life Events Data in Clinical Trials
Quality of Life and Pharmacoeconomics in Clinical Trials
Overview of Phase 4 and Postapproval Clinical Activities
Phase 4 Trials and Postapproval Pharmacovigilance Methodologies
Feasibility of Multinational Trials
Groups that Influence Protocol Design
Monitoring and Auditing a Clinical Trial